<p>The pervasiveness of diabetes type 1 and type 2 has had a notable impact on people's well-being and hampered the healthcare system's sustainability. A study forecasts that around 783.7 million people will live with diabetes by 2045. Strain diabetes puts on the economy and the complications linked to the disease have warranted a holistic approach to develop strategies to minimize prevalence and foster healthcare. There is a general acceptance that physical activity and healthy food habits could reduce obesity rates and diabetes risks. </p><p><b>Researchers, manufacturers and other stakeholders are navigating growth and opportunities in diabetes devices and treatment. The development of advanced treatment options could be pronounced amid the aging population. A healthy lifestyle and better diabetes medications are expected to make a difference in minimizing diabetes. The final report, coupled with the database, will deep-dive into the following dynamics:</b></p><p>•<span style="white-space: pre;"> </span>Decision-making process and customer buying pattern.</p><p>•<span style="white-space: pre;"> </span>Reimbursement landscape and diabetes-related expenditure per person.</p><p>•<span style="white-space: pre;"> </span>Treatment options and related costs across countries.</p><p>•<span style="white-space: pre;"> </span>Comparative prevalence of diabetes.</p><p><b>Get your copy or request a free sample of the report “<a href="https://www.grandviewresearch.com/market-trends/diabetes-type-1-type-2-disease-demographics" target="_blank">Disease Demographics for Diabetes Type 1 and Type 2, 2023</a>,” compiled and published by Grand View Research. </b></p><p><b>Disease Demographics for Diabetes Type 1 and Type 2 Report Scope</b></p><div><table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse: collapse; mso-padding-alt: 0in 0in 0in 0in; mso-yfti-tbllook: 1184; width: 599px;"> <tbody><tr style="mso-yfti-firstrow: yes; mso-yfti-irow: 0;"> <td style="background: rgb(53, 16, 73); border: 1pt solid rgb(127, 105, 164); mso-border-alt: solid #7F69A4 .75pt; padding: 0in; width: 172.1pt;" width="229"> <p class="MsoNormal"><b><span style="color: white; mso-color-alt: windowtext;">Attribute</span></b><o:p></o:p></p> </td> <td style="background: rgb(53, 16, 73); border-left: none; border: 1pt solid rgb(127, 105, 164); mso-border-alt: solid #7F69A4 .75pt; mso-border-left-alt: solid #7F69A4 .75pt; padding: 0in; width: 277.5pt;" width="370"> <p class="MsoNormal"><b><span style="color: white; mso-color-alt: windowtext;">Details</span></b><o:p></o:p></p> </td> </tr> <tr style="mso-yfti-irow: 1;"> <td style="background: rgb(229, 223, 236); border-top: none; border: 1pt solid rgb(176, 154, 213); mso-border-alt: solid #B09AD5 .75pt; mso-border-top-alt: solid #B09AD5 .75pt; padding: 0in; width: 172.1pt;" width="229"> <p class="MsoNormal"><b><span style="color: black; mso-color-alt: windowtext;">Patient Demographics</span></b><o:p></o:p></p> </td> <td style="background: rgb(229, 223, 236); border-bottom: 1pt solid rgb(176, 154, 213); border-left: none; border-right: 1pt solid rgb(176, 154, 213); border-top: none; mso-border-alt: solid #B09AD5 .75pt; mso-border-left-alt: solid #B09AD5 .75pt; mso-border-top-alt: solid #B09AD5 .75pt; padding: 0in; width: 277.5pt;" width="370"> <ul style="margin-top: 0in;" type="disc"> <li class="MsoNormal" style="mso-list: l1 level1 lfo1; tab-stops: list .5in;"><span style="color: black; mso-color-alt: windowtext;">Total Population</span><o:p></o:p></li> <li class="MsoNormal" style="mso-list: l1 level1 lfo1; tab-stops: list .5in;"><span style="color: black; mso-color-alt: windowtext;">People with diabetes</span><o:p></o:p></li> <li class="MsoNormal" style="mso-list: l1 level1 lfo1; tab-stops: list .5in;"><span style="color: black; mso-color-alt: windowtext;">People with undiagnosed diabetes</span><o:p></o:p></li> <li class="MsoNormal" style="mso-list: l1 level1 lfo1; tab-stops: list .5in;"><span style="color: black; mso-color-alt: windowtext;">Deaths attributable to diabetes</span><o:p></o:p></li> </ul> </td> </tr> <tr style="mso-yfti-irow: 2;"> <td style="border-top: none; border: 1pt solid rgb(176, 154, 213); mso-border-alt: solid #B09AD5 .75pt; mso-border-top-alt: solid #B09AD5 .75pt; padding: 0in; width: 172.1pt;" width="229"> <p class="MsoNormal"><b>Treatment Options</b><o:p></o:p></p> </td> <td style="border-bottom: 1pt solid rgb(176, 154, 213); border-left: none; border-right: 1pt solid rgb(176, 154, 213); border-top: none; mso-border-alt: solid #B09AD5 .75pt; mso-border-left-alt: solid #B09AD5 .75pt; mso-border-top-alt: solid #B09AD5 .75pt; padding: 0in; width: 277.5pt;" width="370"> <ul style="margin-top: 0in;" type="disc"> <li class="MsoNormal" style="mso-list: l4 level1 lfo2; tab-stops: list .5in;">Type 1 Diabetes<o:p></o:p></li> <ul style="margin-top: 0in;" type="disc"> <li class="MsoNormal" style="mso-list: l4 level2 lfo2; tab-stops: list 1.0in;">Insulin<o:p></o:p></li> <li class="MsoNormal" style="mso-list: l4 level2 lfo2; tab-stops: list 1.0in;">Diet<o:p></o:p></li> <li class="MsoNormal" style="mso-list: l4 level2 lfo2; tab-stops: list 1.0in;">Blood glucose monitoring<o:p></o:p></li> </ul> <li class="MsoNormal" style="mso-list: l4 level1 lfo2; tab-stops: list .5in;">Type 2 Diabetes<o:p></o:p></li> <ul style="margin-top: 0in;" type="disc"> <li class="MsoNormal" style="mso-list: l4 level2 lfo2; tab-stops: list 1.0in;">Oral Medications<o:p></o:p></li> <li class="MsoNormal" style="mso-list: l4 level2 lfo2; tab-stops: list 1.0in;">Diet<o:p></o:p></li> <li class="MsoNormal" style="mso-list: l4 level2 lfo2; tab-stops: list 1.0in;">Exercise<o:p></o:p></li> <li class="MsoNormal" style="mso-list: l4 level2 lfo2; tab-stops: list 1.0in;">Blood glucose monitoring<o:p></o:p></li> <li class="MsoNormal" style="mso-list: l4 level2 lfo2; tab-stops: list 1.0in;">Insulin<o:p></o:p></li> </ul> </ul> </td> </tr> <tr style="mso-yfti-irow: 3;"> <td style="background: rgb(229, 223, 236); border-top: none; border: 1pt solid rgb(176, 154, 213); mso-border-alt: solid #B09AD5 .75pt; mso-border-top-alt: solid #B09AD5 .75pt; padding: 0in; width: 172.1pt;" width="229"> <p class="MsoNormal"><b><span style="color: black; mso-color-alt: windowtext;">Treatment Cost Per Patient</span></b><o:p></o:p></p> </td> <td style="background: rgb(229, 223, 236); border-bottom: 1pt solid rgb(176, 154, 213); border-left: none; border-right: 1pt solid rgb(176, 154, 213); border-top: none; mso-border-alt: solid #B09AD5 .75pt; mso-border-left-alt: solid #B09AD5 .75pt; mso-border-top-alt: solid #B09AD5 .75pt; padding: 0in; width: 277.5pt;" width="370"> <ul style="margin-top: 0in;" type="disc"> <li class="MsoNormal" style="mso-list: l0 level1 lfo3; tab-stops: list .5in;"><span style="color: black; mso-color-alt: windowtext;">Total diabetes-related health expenditure, USD Million</span><o:p></o:p></li> <li class="MsoNormal" style="mso-list: l0 level1 lfo3; tab-stops: list .5in;"><span style="color: black; mso-color-alt: windowtext;">Diabetes-related health expenditure per person, USD</span><o:p></o:p></li> </ul> </td> </tr> <tr style="mso-yfti-irow: 4;"> <td style="border-top: none; border: 1pt solid rgb(176, 154, 213); mso-border-alt: solid #B09AD5 .75pt; mso-border-top-alt: solid #B09AD5 .75pt; padding: 0in; width: 172.1pt;" width="229"> <p class="MsoNormal"><b>Quality of Life</b><o:p></o:p></p> </td> <td style="border-bottom: 1pt solid rgb(176, 154, 213); border-left: none; border-right: 1pt solid rgb(176, 154, 213); border-top: none; mso-border-alt: solid #B09AD5 .75pt; mso-border-left-alt: solid #B09AD5 .75pt; mso-border-top-alt: solid #B09AD5 .75pt; padding: 0in; width: 277.5pt;" width="370"> <ul style="margin-top: 0in;" type="disc"> <li class="MsoNormal" style="mso-list: l2 level1 lfo4; tab-stops: list .5in;">Disability-adjusted life years (DALYs)<o:p></o:p></li> </ul> </td> </tr> <tr style="mso-yfti-irow: 5;"> <td style="background: rgb(229, 223, 236); border-top: none; border: 1pt solid rgb(176, 154, 213); mso-border-alt: solid #B09AD5 .75pt; mso-border-top-alt: solid #B09AD5 .75pt; padding: 0in; width: 172.1pt;" width="229"> <p class="MsoNormal"><b><span style="color: black; mso-color-alt: windowtext;">Comorbidity Analysis</span></b><o:p></o:p></p> </td> <td style="background: rgb(229, 223, 236); border-bottom: 1pt solid rgb(176, 154, 213); border-left: none; border-right: 1pt solid rgb(176, 154, 213); border-top: none; mso-border-alt: solid #B09AD5 .75pt; mso-border-left-alt: solid #B09AD5 .75pt; mso-border-top-alt: solid #B09AD5 .75pt; padding: 0in; width: 277.5pt;" width="370"> <ul style="margin-top: 0in;" type="disc"> <li class="MsoNormal" style="mso-list: l6 level1 lfo5; tab-stops: list .5in;"><span style="color: black; mso-color-alt: windowtext;">Diabetic foot ulcer</span><o:p></o:p></li> <li class="MsoNormal" style="mso-list: l6 level1 lfo5; tab-stops: list .5in;"><span style="color: black; mso-color-alt: windowtext;">Cardiovascular disease (CVD)</span><o:p></o:p></li> <li class="MsoNormal" style="mso-list: l6 level1 lfo5; tab-stops: list .5in;"><span style="color: black; mso-color-alt: windowtext;">Diabetic retinopathy</span><o:p></o:p></li> <li class="MsoNormal" style="mso-list: l6 level1 lfo5; tab-stops: list .5in;"><span style="color: black; mso-color-alt: windowtext;">Diabetic neuropathy</span><o:p></o:p></li> <li class="MsoNormal" style="mso-list: l6 level1 lfo5; tab-stops: list .5in;"><span style="color: black; mso-color-alt: windowtext;">Diabetic nephropathy</span><o:p></o:p></li> </ul> </td> </tr> <tr style="mso-yfti-irow: 6;"> <td style="border-top: none; border: 1pt solid rgb(176, 154, 213); mso-border-alt: solid #B09AD5 .75pt; mso-border-top-alt: solid #B09AD5 .75pt; padding: 0in; width: 172.1pt;" width="229"> <p class="MsoNormal"><b>Reimbursement Differences</b><o:p></o:p></p> </td> <td style="border-bottom: 1pt solid rgb(176, 154, 213); border-left: none; border-right: 1pt solid rgb(176, 154, 213); border-top: none; mso-border-alt: solid #B09AD5 .75pt; mso-border-left-alt: solid #B09AD5 .75pt; mso-border-top-alt: solid #B09AD5 .75pt; padding: 0in; width: 277.5pt;" width="370"> <ul style="margin-top: 0in;" type="disc"> <li class="MsoNormal" style="mso-list: l5 level1 lfo6; tab-stops: list .5in;">Coverage for Medicare and Medicaid<o:p></o:p></li> <ul style="margin-top: 0in;" type="disc"> <li class="MsoNormal" style="mso-list: l5 level2 lfo6; tab-stops: list 1.0in;">Type 1 Diabetes<o:p></o:p></li> <li class="MsoNormal" style="mso-list: l5 level2 lfo6; tab-stops: list 1.0in;">Type 2 Diabetes<o:p></o:p></li> </ul> </ul> </td> </tr> <tr style="mso-yfti-irow: 7; mso-yfti-lastrow: yes;"> <td style="background: rgb(229, 223, 236); border-top: none; border: 1pt solid rgb(176, 154, 213); mso-border-alt: solid #B09AD5 .75pt; mso-border-top-alt: solid #B09AD5 .75pt; padding: 0in; width: 172.1pt;" width="229"> <p class="MsoNormal"><b><span style="color: black; mso-color-alt: windowtext;">Regions</span></b><o:p></o:p></p> </td> <td style="background: rgb(229, 223, 236); border-bottom: 1pt solid rgb(176, 154, 213); border-left: none; border-right: 1pt solid rgb(176, 154, 213); border-top: none; mso-border-alt: solid #B09AD5 .75pt; mso-border-left-alt: solid #B09AD5 .75pt; mso-border-top-alt: solid #B09AD5 .75pt; padding: 0in; width: 277.5pt;" width="370"> <ul style="margin-top: 0in;" type="disc"> <li class="MsoNormal" style="mso-list: l3 level1 lfo7; tab-stops: list .5in;"><span style="color: black; mso-color-alt: windowtext;">North America</span><o:p></o:p></li> <ul style="margin-top: 0in;" type="disc"> <li class="MsoNormal" style="mso-list: l3 level2 lfo7; tab-stops: list 1.0in;"><span style="color: black; mso-color-alt: windowtext;">U.S.</span><o:p></o:p></li> <li class="MsoNormal" style="mso-list: l3 level2 lfo7; tab-stops: list 1.0in;"><span style="color: black; mso-color-alt: windowtext;">Canada</span><o:p></o:p></li> </ul> <li class="MsoNormal" style="mso-list: l3 level1 lfo7; tab-stops: list .5in;"><span style="color: black; mso-color-alt: windowtext;">Europe</span><o:p></o:p></li> <ul style="margin-top: 0in;" type="disc"> <li class="MsoNormal" style="mso-list: l3 level2 lfo7; tab-stops: list 1.0in;"><span style="color: black; mso-color-alt: windowtext;">UK</span><o:p></o:p></li> <li class="MsoNormal" style="mso-list: l3 level2 lfo7; tab-stops: list 1.0in;"><span style="color: black; mso-color-alt: windowtext;">Germany</span><o:p></o:p></li> <li class="MsoNormal" style="mso-list: l3 level2 lfo7; tab-stops: list 1.0in;"><span style="color: black; mso-color-alt: windowtext;">France</span><o:p></o:p></li> <li class="MsoNormal" style="mso-list: l3 level2 lfo7; tab-stops: list 1.0in;"><span style="color: black; mso-color-alt: windowtext;">Italy</span><o:p></o:p></li> <li class="MsoNormal" style="mso-list: l3 level2 lfo7; tab-stops: list 1.0in;"><span style="color: black; mso-color-alt: windowtext;">Spain</span><o:p></o:p></li> <li class="MsoNormal" style="mso-list: l3 level2 lfo7; tab-stops: list 1.0in;"><span style="color: black; mso-color-alt: windowtext;">Denmark</span><o:p></o:p></li> <li class="MsoNormal" style="mso-list: l3 level2 lfo7; tab-stops: list 1.0in;"><span style="color: black; mso-color-alt: windowtext;">Sweden</span><o:p></o:p></li> <li class="MsoNormal" style="mso-list: l3 level2 lfo7; tab-stops: list 1.0in;"><span style="color: black; mso-color-alt: windowtext;">Norway</span><o:p></o:p></li> </ul> <li class="MsoNormal" style="mso-list: l3 level1 lfo7; tab-stops: list .5in;"><span style="color: black; mso-color-alt: windowtext;">Asia Pacific</span><o:p></o:p></li> <ul style="margin-top: 0in;" type="disc"> <li class="MsoNormal" style="mso-list: l3 level2 lfo7; tab-stops: list 1.0in;"><span style="color: black; mso-color-alt: windowtext;">Japan</span><o:p></o:p></li> <li class="MsoNormal" style="mso-list: l3 level2 lfo7; tab-stops: list 1.0in;"><span style="color: black; mso-color-alt: windowtext;">China</span><o:p></o:p></li> <li class="MsoNormal" style="mso-list: l3 level2 lfo7; tab-stops: list 1.0in;"><span style="color: black; mso-color-alt: windowtext;">India</span><o:p></o:p></li> <li class="MsoNormal" style="mso-list: l3 level2 lfo7; tab-stops: list 1.0in;"><span style="color: black; mso-color-alt: windowtext;">Australia</span><o:p></o:p></li> <li class="MsoNormal" style="mso-list: l3 level2 lfo7; tab-stops: list 1.0in;"><span style="color: black; mso-color-alt: windowtext;">Thailand</span><o:p></o:p></li> <li class="MsoNormal" style="mso-list: l3 level2 lfo7; tab-stops: list 1.0in;"><span style="color: black; mso-color-alt: windowtext;">South Korea</span><o:p></o:p></li> </ul> <li class="MsoNormal" style="mso-list: l3 level1 lfo7; tab-stops: list .5in;"><span style="color: black; mso-color-alt: windowtext;">Latin America</span><o:p></o:p></li> <ul style="margin-top: 0in;" type="disc"> <li class="MsoNormal" style="mso-list: l3 level2 lfo7; tab-stops: list 1.0in;"><span style="color: black; mso-color-alt: windowtext;">Brazil</span><o:p></o:p></li> <li class="MsoNormal" style="mso-list: l3 level2 lfo7; tab-stops: list 1.0in;"><span style="color: black; mso-color-alt: windowtext;">Mexico</span><o:p></o:p></li> <li class="MsoNormal" style="mso-list: l3 level2 lfo7; tab-stops: list 1.0in;"><span style="color: black; mso-color-alt: windowtext;">Argentina</span><o:p></o:p></li> </ul> <li class="MsoNormal" style="mso-list: l3 level1 lfo7; tab-stops: list .5in;"><span style="color: black; mso-color-alt: windowtext;">MEA</span><o:p></o:p></li> <ul style="margin-top: 0in;" type="disc"> <li class="MsoNormal" style="mso-list: l3 level2 lfo7; tab-stops: list 1.0in;"><span style="color: black; mso-color-alt: windowtext;">South Africa</span><o:p></o:p></li> <li class="MsoNormal" style="mso-list: l3 level2 lfo7; tab-stops: list 1.0in;"><span style="color: black; mso-color-alt: windowtext;">Saudi Arabia</span><o:p></o:p></li> <li class="MsoNormal" style="mso-list: l3 level2 lfo7; tab-stops: list 1.0in;"><span style="color: black; mso-color-alt: windowtext;">UAE</span><o:p></o:p></li> <li class="MsoNormal" style="mso-list: l3 level2 lfo7; tab-stops: list 1.0in;"><span style="color: black; mso-color-alt: windowtext;">Kuwait</span><o:p></o:p></li> </ul> </ul> </td> </tr> </tbody></table><br /></div><div><div><b>Related Reports:</b></div><div><b>•<span style="white-space: pre;"> </span><a href="https://www.grandviewresearch.com/industry-analysis/diabetes-devices-market" target="_blank">Diabetes Devices Market Size, Share & Trends Analysis Report By Type (BGM Devices, Insulin Delivery Devices), By Distribution Channel, By End Use (Hospitals, Homecare), By Region, And Segment Forecasts, 2022 - 2030</a><span style="white-space: pre;"> </span><br /><br /></b></div><div><b>•<span style="white-space: pre;"> </span><a href="https://www.grandviewresearch.com/industry-analysis/diabetes-associated-ophthalmic-treatment-market-report" target="_blank">Diabetes Associated Ophthalmic Treatment Market Size, Share & Trends Analysis Report By Type (Drugs, Devices), By Application (Dry Eye, Glaucoma, Diabetic Retinopathy, DAMD, Uveitis, Cataract), By End-use, By Region, And Segment Forecasts, 2021 - 2028</a></b></div><div><b><br /></b></div><div><b>About Us</b></div><div>Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights.<br /><b><br /></b></div><div><b>Find More information @ <a href="https://www.grandviewresearch.com/info/trend-reports" target="_blank">https://www.grandviewresearch.com/info/trend-reports</a></b></div></div>
Topics
